Rhizocalin is the first two-headed sphingolipid like compound isolated from the sponge Rhizochalina incrustata.
Aglycon of Rhizochalin from the Rhizochalina incrustata Induces Apoptosis via Activation of AMP-Activated Protein Kinase in HT-29 Colon Cancer Cells
and were pure in accordance with NMR, MS, TLC, and HPLC data.
1,2)
Cell Culture Human colon cancer HT-29 cells were obtained from the American Type Culture Collection (ATCC, Manassas, VA, U.S.A.). The cells were cultured in McCoy's 5A medium supplemented with 10% fetal bovine serum, glutamine, and antibiotics (100 U/ml penicillin, 100 mg/ml streptomycin). JB6 Cl41 mouse epidermal cells were cultured in MEM supplemented with 5% FBS. Dimethyl sulfoxide (DMSO) was used as a vehicle to dissolve the compound and a final concentration of 0.1% DMSO (v/v) was used for each treatment.
MTT Assay The MTT assay was performed to check cell viability. In brief, cells (1ϫ10 5 cells/ml) were seeded in 96-well plates with 100 ml of cell suspension in each well. After culturing for 24 h, cells were treated with AglRhz. The cells were then treated with 5 mg/ml MTT solution (10 ml/well) and incubated for 3 h, after which the purple formazan formed by the live cells was dissolved in 0.04 N HCl in isopropanol (100 ml/well) and the absorbance was measured at 570 nm.
Immunoblot Analysis The cells were disrupted in lysis buffer [50 mM Tris (pH 7.5), 5 mM ethylenediaminetetraacetic acid (EDTA), 150 mM NaCl, 1 mM dithiothreitol, 0.01% Nonidet P-40, 0.2 mM phenylmethylsulfonyl fluoride, and protease inhibitor cocktail]. The proteins were resolved by sodium dodecyl sulfate (SDS)-polyacrylamide gel electrophoresis and transferred onto polyvinylidene difluoride membranes. The membranes were blocked and hybridized with the appropriate primary antibody overnight at 4°C. The protein bands were visualized using a chemiluminescence detection kit (Amersham HRP Chemiluminescent Substrates, Amersham Biosciences, Piscataway, NJ, U.S.A.) after hybridization with the HRP-conjugated secondary antibody from rabbits or mice. The LAS3000-mini (Fujifilm, Tokyo, Japan) was used for chemiluminescence detection.
Detection of Apoptosis The induction of apoptosis was assessed by terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) staining and detected with an in situ Cell Death detection Kit (Roche Applied Science, Indianapolis, IN, U.S.A.) according to manufacturer's instructions. In short, 2ϫ10 5 cells were cultured for 24 h in 6-well plates. The cells were treated with 1% FBS media for 24 h and treated with AglRhz for 6 h. The cells were then washed with phosphate-buffered saline (PBS) and fixed with Cytofix/Cytoperm at 4°C for 20 min. Then cells were stained with 50 ml TUNEL solution and incubated at 37°C for 1 h. The cells were washed with PBS twice and the cells were fixed. DNA fragmentation was detected using an Axiovert 200 M fluorescence microscope and quantified with Axio Vision software (Carl Zeiss Inc., Thornwood, NY, U.S.A.).
Reporter Gene Assays The reporter gene assay for firefly luciferase activity was performed using lysates from AP-1-luc-or c-fos-luc-transfected HT-29 cells treated with AglRhz. The reporter gene vector, phRL-SV40 (Promega), was co-transfected into each cell line and the Renilla luciferase activity generated by this vector was used for normalization to the calculated transfection efficiency. Cell lysates were prepared by first washing the transfected HT-29 cells once in PBS at room temperature. After the PBS was completely removed, passive lysis buffer (PLB, Promega) was added to each well, and then cells were incubated at room temperature for 1 h with gentle shaking. The supernatant fraction was used to measure firefly and renilla luciferase activities. Cell lysates were mixed with luciferase assay II reagent (Promega), and firefly luciferase light emission was measured on a TriStar LB 941 (Berthold Tech. GmbHand Co., KG, Germany). Subsequently, renilla luciferase substrate (Promega) was added to allow normalization of firefly luciferase data. The AP-1 luciferase reporter plasmid was kindly provided by Dr. Jeong (College of Pharmacy, Chosun University, Gwangju, Korea). The c-fos-lucpromoter luciferase plasmid was kindly provided by Dr. Ron Prywes (Columbia University, New York, NY, U.S.A.).
Apoptosis Assessed by Flow Cytometry The induction of early and late apoptosis was analyzed by flow cytometry using the Becton Dickinson FACS Calibur Flow Cytometer (BD Biosciences). HT-29 cells (5ϫ10 5 per dish) were grown in 6-cm dishes for 24 h in 1% FBS media. Then, cells were cultured with 1% FBS media for 24 h and treated with AglRhz for 24 h. The medium was collected and attached cells were harvested with 0.025% trypsin in 5 mM EDTA in PBS. Cells were processed for detection of early and late apoptosis using Annexin V-fluorescein isothiocyanate (FITC) and propidium iodide staining according to the manufacturer's protocol.
Anchorage-Independent Cell Transformation Assay (Soft Agar Assay) The inhibition of cell transformation of HT-29 cells by AglRhz was tested in a soft agar assay. In brief, 8ϫ10 3 cells/ml were seeded in 1 ml of 0.3% basal medium Eagle (BME) agar containing 10% FBS, 2 mM Lglutamine, and 25 mg/ml gentamicin with AglRhz. The cultures were maintained at 37°C for 2 weeks, and cell colonies were scored using an Axiovert 200 M fluorescence microscope and Axio Vision software (Carl Zeiss Inc., Thornwood, NY, U.S.A.).
Statistical Analysis Statistical calculations were carried out with Prism 4 for Macintosh software (GraphPad Software. Inc., La Jolla, CA, U.S.A.). Results are expressed as the meanϮS.E.M. of triplicate measurements of two independent experiments. Student's t-test was used for statistical analyses; p values Ͻ0.05 were considered to be significant.
RESULTS

AglRhz Induces Cell Death in HT-29 Cells
AglRhz is a two-headed sphingolipid-like compound with a rare a,wbifunctionalized structure 3) (Fig. 1A) . To determine the antitumor effect of AglRhz in HT-29 cells, we first examined cell viability after AglRhz treatment dose-and time-dependently using MTT assay. The treatment of AglRhz significantly inhibited viability of HT-29 cells (Fig. 1B) .
AglRhz Induces Phosphorylation of AMPK and Inhibits mTOR-p70S6K-ERK Signaling Since AMPK plays a critical role in cell growth and it can be also target for cancer therapy, 15) we first examined whether AglRhz increases AMPK activity. As shown in Figs. 2A and B, AglRhz increased the phosphorylation of AMPK time-and dose-dependently. However, AMPK activation by AglRhz was inhibited by compound C, a potent AMPK inhibitor (Fig. 2C) . AMPK inhibits mammalian target of rapamycin C1 (mTORC1) through phosphorylation of TSC2 and Raptor. 16) In addition, mTORC1 induces p70S6K phosphorylation, which is required for regulation of cell growth, protein synthesis and G1/S transition. 17, 18) Our result showed that AglRhz induced phosphorylation of Raptor on S792, and thereby inhibited phosphorylation of p70S6K. Since it was reported that the p70S6K interacts with ERK1/2 and enhances phosphorylation of ERK induced by insulin, 19) we next investigated whether activation of AMPK by AglRhz regulates mTOR-p70S6K-ERK signaling. As shown in Fig.  2E , phosphorylation of ERK1/2 is downregulated by AglRhz dose-dependently. AglRhz also inhibited IGF-induced phosphorylation of p70S6K and ERK1/2 via activation of Raptor (Fig. 2F) . These overall data suggest that AglRhz has inhibitory effects on the activity of p70S6K as well as ERK1/2 via induction of AMPK-dependent Raptor phosphorylation.
AglRhz Inhibits c-fos and AP-1 Promoter Activity The mitogen activated protein (MAP) kinase signaling pathways plays an important role in AP-1 activation, which is the dimerized protein of Fos proteins and Jun proteins. 20, 21) Since AglRhz inhibited mTOR-p70S6K-ERK signaling by activation of AMPK in Fig. 2 , we therefore wish to determine whether inhibition of ERK by AglRhz affects the promoter activity of c-fos and AP-1. As shown in Figs. 3A and B, AglRhz inhibited the promoter activity of c-fos as well as AP-1 dose-dependently. In addition, AglRhz inhibited IGF-Iinduced luciferase activity of c-fos and AP-1 (Figs. 3C, D) . These data support our notion that the suppression of c-fos and AP-1 promoter activity is one of the mechanisms explaining the anti-tumorigenetic effect of AglRhz.
AglRhz Induces Apoptosis Signaling and DNA Fragmentation in HT-29 Cells Next, we investigated whether AglRhz-induced AMPK activation is associated with the apoptosis-signaling pathway in HT-29 cells. AglRhz induced cleavage of caspase-3 and PARP dose-and time-dependently (Figs. 4A, B) . We also measured DNA fragmentation by TUNEL staining. The degree of TUNEL staining markedly increased after AglRhz treatment (Fig. 4C) . In addition, AglRhz induced the apoptosis of HT-29 cells, which were characterized by a rate of total apoptosis that reached 9.2% cell death at 5 mM AglRhz (Fig. 4D) . Overall, these data provide strong evidence indicating that AglRhz induced apoptosis via activation of caspase-3 and PARP, and DNA fragmentation in HT-29 cells.
AglRhz Inhibits IGF-I-Induced Neoplastic Cell Transformation of JB6 Cl41 Cells and Tumorigenicity of HT-29 Cells Next, we assessed the effect of AMPK activation by AglRhz on the cell transformation of JB6 Cl41 cells and tumorigenicity of HT-29 cells by soft agar colony formation.
The JB6 Cl41 cell system is a well-developed model for studying tumor promotion induced by tumor promoter, such as EGF and TPA, under anchorage independent growth condition. 22) AglRhz significantly inhibited IGF-I-induced neoplastic cell transformation of JB6 Cl41 cells dose-dependently (Figs. 5A, B) . Next, to assess whether AglRhz inhibit ed tumorigenicity of HT-29 cells, the cells were treated with AglRhz (0.1, 0.25, 0.5 mM) in soft agar. AglRhz decreased colony numbers as well as colony sizes in HT-29 cells compared with control cells (Figs. 5C, D) . Taken together, these data strongly support the idea that AglRhz plays an inhibitory role in neoplastic cell transformation of JB6 Cl41 
DISCUSSION
The chemical and biological diversity of the marine environment is immeasurable and therefore is an extraordinary resource for the discovery of new anticancer drugs.
23) The past decade has seen a dramatic increase in the number of preclinical anticancer lead compounds from diverse marine life entering human clinical trials. 23) Marine sponges especially have been considered as a promising natural resource for the past 50 years, with respect to the diversity of their secondary metabolites. The biological effects of new metabolites from sponges have been reported, and sponges have the potential to provide future drugs against important diseases, such as cancer, a range of viral diseases, malaria, and inflammation. 24) Rhizochalin is two-headed sphingolipid from the marine sponge Rhizochalina incrustata, and it is striking because of its rare structure and high biological activity.
3) After the first isolation of rhizochalin, many other two-headed sphingolipids are isolated from marine sponges, some of which are studied as antitumor agents. 2, 3) AglRhz has been reported to inhibit the viability of cancer cells including leukemia, uterine, cervical, and colon cancer. 2, 3) However, the anticancer mechanism remains poorly defined. Here, we show the first evidence that AMPK may play a role in mediating the anticancer effect of AglRhz in colon cancer cells.
AMPK has a role in metabolism and cell growth regulation and emerges as a novel therapeutic target for the treatment of cancers or other metabolic disorders such as obesity and type-2 diabetes. 15) Quercetin, a major dietary flavonoid, and 24-hydroxyursolic acid from the leaves of the Diospyros kaki (persimmon) induces apoptosis via AMPK activation and p53-dependent apoptotic cell death in HT-29 cells. 13, 14) In addition, resveratrol, a polyphenolic natural product, 25) induces apoptosis in HT-29 cells via AMPK activation. 26) Our findings demonstrated that AglRhz is able to increase phosphorylation of AMPK and decrease cell viability in HT-29 cells (Figs. 1B, 2A, B) . It is reported that AMPK inhibition using compound C, a selective and ATP-competitive inhibitor of AMPK, reversed the effect of AICAR, an AMPK activator. 27, 28) Our results showed that the phosphorylation of AMPK induced by AglRhz was inhibited by compound C (Fig. 2C) , suggesting that AglRhz may exert its antitumor effect in HT-29 cells via AMPK activation.
AMPK serves as a negative regulator for mTORC1, a functional complex of mTOR, via direct phosphorylation of both TSC2 tumor suppressor and the mTORC1 binding partner, Raptor. 29, 30) Blockade of mTORC1 by AMPK is vital in determining apoptotic or growth arrest in cells in response to glucose deprivation or hypoxia.
31) The p70S6K protein, which is directly downstream of mTORC1, is a mitogen activated Ser/Thr protein kinase.
32) The mTOR-p70S6K signaling pathway has a major role in cell growth by integrating growth factor and nutrient cascades. 33) In addition, this pathway is essential for cellular homeostasis and aberrant modulation of this pathway can contribute to cancer and metabolic disorders such as obesity and type 2 diabetes. 33) In accordance with these previous reports, AglRhz induced phosphorylation of both AMPK and Raptor and p70S6K activity is downregulated by AglRhz (Fig. 2D) . These data indicate that AglRhz inhibited p70S6K phosphorylation through the AMPK-Raptor pathway. It is known that IGF-I is a potent activator of the AKT-mTOR-p70S6K signaling pathway and has a role in cell growth and proliferation, and is antiapo ptotic. 34, 35) To confirm AglRhz's effects on Raptor-p70S6K pathway, we examined whether IGF-I induced p70S6K is affected by AglRhz. As expected, IGF-I induced p70S6K phosphorylation, which was blocked by AglRhz treatment in HT-29 cells (Fig. 2F) . Taken together, these data indicate that, upon both IGF-I stimulation and normal condition, AglRhz has an effect on the mTOR-p70S6K signaling pathway via AMPK activation.
The ERK signaling pathway has been studied extensively and is a central MAPK pathway that plays a role in cell proliferation, differentiation and transformation.
36) The MAP kinase signaling pathways are critical for AP-1 activation. 20) Additionally, AP-1 plays a pivotal role in tumorigenesis and its activity is increased in multiple human tumor types. 37) AP-1 in human colon cancer cell lines mediates an antiapoptotic response to the hypoxic conditions often encountered in the environment of soild tumors and thus contributes to chemo-and radiotherapy resistance. 38) Recently, it was reported that MAP kinase is regulated by mTOR-p70S6K signaling in hepatocarcinoma cells. 19) More specifically, the insulin-induced interaction of p70S6K with ERK1/2 resulted in augmentation of its downstream target gene such as AP-1, and this interaction was blocked by rapamycin, suggesting that insulin-mediated crosstalk exists between p70S6K and ERK1/2. 19) Here we showed that AglRhz inhibited ERK phosphorylation (Figs. 2E, F) and AP-1 activity (Fig. 3) , suggesting that ERK-AP-1 signaling might be blocked through AglRhz's inhibitory effect on mTOR-p70S6K signaling pathway via AMPK-Raptor activation. Furthermore, individuals with high-normal circulating IGF-I levels are at an increased risk of later development of common solid tumors. 34, 39) Consistent with this, tumor growth in experimental models is influenced by circulating IGF levels. 34, 39) Our findings demonstrated that AglRhz inhibited IGF-I-induced AP-1 activity, suggesting that IGF-I induced ERK-AP-1 signaling also might be blocked through the inhibitory effect of AglRhz on mTOR-p70S6K.
In summary, our study showed that AglRhz strongly induces AMPK activity, and thereby inhibits mTOR-p70S6K signaling pathway via phosphorylation of Raptor, resulting in the inhibition of ERK1/2 phosphoryaltion and AP-1 activity. In addition, AglRhz increases apoptosis via cleavage of caspase-3, PARP, and DNA fragmentation in HT-29 cells. Furthermore, AglRhz significantly inhibits IGF-I induced neoplastic cell transformation of JB6 Cl41 cells and the tumorigenicity of HT-29 colon cancer cells in soft agar. Together these results suggest that AMPK is a potent molecular target for the suppression of tumorigenicity of HT-29 colon cancer cells by AglRhz, and its activation may partially account for the reported anticancer effects of Sponge.
